RecruitingNot Applicable

Ventricular Tachycardia Mechanisms

United States10 participantsStarted 2022-10-25

Plain-language summary

The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of ischemic cardiomyopathy * Single or dual chamber implantable cardioverter-defibrillator (ICD) Exclusion Criteria: * Non-Ischemic cardiomyopathy * Contraindication to catheter ablation * Severe peripheral arterial disease or medical condition that prohibit arterial access * Ventricular tachycardia (VT) or sudden cardiac arrest (SCA) within 30 days of acute coronary syndrome or within 90 days of coronary revascularization

What they're measuring

Waveform Morphology

Timeframe: During ablation on Day 1

Conduction Velocity

Timeframe: During ablation on Day 1

Trial details

NCT IDNCT05478213

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05

Contact for this trial

Neal Bhatia, MD

404-686-7878 neal.kumar.bhatia@emory.edu

View on ClinicalTrials.gov More Ventricular Tachycardia trials